HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 129 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $857,000 | -35.8% | 96,676 | -8.4% | 0.00% | -50.0% |
Q2 2022 | $1,334,000 | -17.2% | 105,545 | +23.9% | 0.00% | 0.0% |
Q1 2022 | $1,612,000 | -53.2% | 85,200 | -13.3% | 0.00% | -50.0% |
Q4 2021 | $3,446,000 | -4.2% | 98,220 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $3,596,000 | -6.8% | 98,220 | 0.0% | 0.00% | -20.0% |
Q2 2021 | $3,857,000 | +39.0% | 98,220 | 0.0% | 0.01% | +25.0% |
Q1 2021 | $2,775,000 | -11.8% | 98,220 | 0.0% | 0.00% | -20.0% |
Q4 2020 | $3,145,000 | -0.9% | 98,220 | 0.0% | 0.01% | -16.7% |
Q3 2020 | $3,173,000 | -1.6% | 98,220 | -16.0% | 0.01% | -14.3% |
Q2 2020 | $3,225,000 | +367.4% | 116,920 | +202.3% | 0.01% | +250.0% |
Q1 2020 | $690,000 | -58.6% | 38,674 | -41.8% | 0.00% | -33.3% |
Q4 2019 | $1,667,000 | -2.0% | 66,484 | -14.0% | 0.00% | 0.0% |
Q2 2019 | $1,701,000 | -28.1% | 77,334 | 0.0% | 0.00% | -40.0% |
Q1 2019 | $2,365,000 | +32.5% | 77,334 | 0.0% | 0.01% | +25.0% |
Q4 2018 | $1,785,000 | – | 77,334 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zeal Asset Management Ltd | 2,684,118 | $84,523,000 | 16.48% |
Cederberg Capital Ltd | 3,400,000 | $108,868,000 | 2.00% |
Capital International Sarl | 570,500 | $18,267,000 | 1.91% |
AIA Group Ltd | 437,118 | $14,971,000 | 1.72% |
Capital International, Inc./CA/ | 4,711,405 | $150,859,000 | 1.40% |
M&G INVESTMENT MANAGEMENT LTD | 3,096,345 | $99,083,000 | 0.62% |
Bellevue Group AG | 947,674 | $30,345,000 | 0.35% |
Sands Capital Management | 7,051,916 | $225,802,000 | 0.22% |
E Fund Management (Hong Kong) Co., Ltd. | 18,836 | $603,000 | 0.21% |
Hudson Bay Capital Management LP | 1,031,212 | $33,020,000 | 0.18% |